证券记录 · 已归档季度
PRCT
PROCEPT BioRobotics Corporation · Healthcare · Medical - Devices
13被追踪持有人
+2Δ持有人
6.67M持有股份
$388.41M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +18.2% ·
股份流向 +7.8% ·
净新建仓位 +15.4%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +5 | 33.31M | $752.45M | +11 | −5 |
| Q1 2026 | 91 | -1 | 33.28M | $833.46M | +12 | −14 |
| Q4 2025 | 93 | +1 | 39.36M | $1.24B | +3 | −1 |
| Q3 2025 | 16 | -3 | 25.33M | $904.19M | — | −3 |
| Q2 2025 | 16 | 0 | 23.48M | $1.35B | +1 | −1 |
| Q1 2025 | 13 | +2 | 6.67M | $388.41M | +2 | — |
| Q4 2024 | 11 | 0 | 6.19M | $498.09M | +1 | −1 |
| Q3 2024 | 10 | -1 | 3.73M | $299.03M | — | −1 |
| Q2 2024 | 11 | — | 4.04M | $246.80M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 1.19M | -0.1% | $69.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.18M | +1.7% | $68.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.18M | +1.7% | $68.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.06M | +47.9% | $61.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.06M | +47.9% | $61.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 962.24K | -35.5% | $56.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 542.99K | +88.6% | $31.63M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 480.69K | +35.9% | $28.01M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 428.90K | -29.4% | $24.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 314.47K | +12.9% | $18.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 313.88K | 新增 | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 313.88K | 新增 | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 313.88K | 新增 | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 313.88K | 新增 | $18.29M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 114.82K | +1186.1% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 50.00K | 新增 | $2.91M | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 18.89K | +7.3% | $1.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 12.95K | -82.5% | $754,350 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Baillie Gifford | $18.29M | 0.0% |
| Adage Capital Partners | $2.91M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 254 持有人, 55.53M 股份, $1.28B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 07
Wood Larry L
Officer, Director · President, CEO · 23.90K 股 @ 20.85 · $498,315
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 29
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据